login
login

Europe Daily Bulletin No. 12472

23 April 2020
Contents Publication in full By article 24 / 33
ECONOMY - FINANCE - BUSINESS / Competition
Commission clears merger between Mylan and Pfizer's Upjohn division subject to conditions
Brussels, 22/04/2020 (Agence Europe)

The European Commission on Wednesday 22 April cleared the proposed merger between global pharmaceutical company Mylan of the Netherlands and Upjohn of China, a division of Pfizer that operates its 'off-patent branded and generic established medicines' business. The decision is subject to the divestment of Mylan's business for certain generic medicines.

Margrethe Vestager, Executive Vice President in charge of Competition Policy, said "Our decision ensures that the merger between Mylanand...

Contents

EU RESPONSE TO COVID-19
INSTITUTIONAL
SECTORAL POLICIES
EXTERNAL ACTION
SOCIAL AFFAIRS
ECONOMY - FINANCE - BUSINESS
COUNCIL OF EUROPE
NEWS BRIEFS